Advanced Biomed ADVB
NASDAQ ADVB
$6.86 -0.17 (-2.42%)
As of: Oct 2, 2026 · 9:32 AM EDT

Advanced Biomed (ADVB) Return on Assets [ROA] (2025 - 2026)

Updated

Advanced Biomed's Return on Assets [ROA] came in at 41.73% for fiscal Q3 2026 (quarter ended Mar 31, 2026), up 94.37 percentage points from -52.64% a year earlier but down 0.28 percentage points from the prior quarter.

Analysis

Advanced Biomed (ADVB) Return on Assets [ROA] (2025 - 2026) Analysis & Trends

For FY2025 (ended Jun 30, 2025), Advanced Biomed's Return on Assets [ROA] was -35.86%.

  • The five-year range for quarterly Return on Assets [ROA] is -52.64% (fiscal Q3 2025) to 42.01% (fiscal Q2 2026).
  • Business Quant data shows ADVB's Return on Assets [ROA] at 42.01% (Q2 2026), -41.84% (Q1 2026) and -36.85% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 6.17%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 4.94%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 4.54%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 15.41%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 5.66%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -1.94%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 8.19%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 7.38%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 1.85%
10 Advanced Biomed 8.61 Mn 8.61 Mn - 41.73%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 41.73%
Dec 31, 2025 42.01%
Sep 30, 2025 -41.84%
Jun 30, 2025 -36.85%
Mar 31, 2025 -52.64%
API Access

Advanced Biomed Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ADVB&period=max&api_key=YOUR_API_KEY